Skip to main content

Table 1 Patients had preexisting T cells to multiple prostate-specific proteins. Shown are the number and % of patients with IFNγ-, granzyme B- (Grz), IL-10-, or IL-6-secreting responses to one or more (or none) of the three prostate cancer-associated proteins (PAP, PSA or AR)

From: Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination

  IFNγ Grz IL-10 IL-6
n (%) n (%) n (%) n (%)
None 4 (13.3) 3 (10) 1 (3.3) 9 (30)
PAP 0 0 0 0
PSA 0 0 0 0
AR 2 (6.6) 3 (10) 4 (13.3) 0
PAP + PSA 0 0 0 0
PSA + AR 0 1 (3.3) 0 0
PAP + AR 9 (30) 7 (23.3) 9 (30) 13 (43)
PAP + AR + PSA 15 (50) 16 (53.3) 16 (53.3) 8 (27)